Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ir-CPI in Spontaneous Intracerebral Haemorrhage
NCT05970224Phase 2Completed
- Sponsor
- Bioxodes
- Start
- Nov 2023
- Primary completion
- Mar 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of BIOX-101 in intracerebral hemorrhage (ICH), sponsored by Bioxodes. Started Nov 2023; status: completed.
02
Drugs
BIOX-101
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05970224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970224.